Literature DB >> 23446237

[Sexually transmitted infections: update 2013].

Stephan Lautenschlager1.   

Abstract

Although there have been significant advances in diagnosis, treatment, and education, the occurence of STI continues to increase worldwide as well as in Switzerland. The most common STI include human papillomavirus (HPV), chlamydia, herpes, simplex virus types 1 and 2, gonorrhea, syphilis, hepatitis B and trichomoniasis. Diagnosis and treatment continue to be major public health challenges because of the asymptomatic nature of many of these infections. Recent studies showed favorable epidemiologic trends for HPV infection in vaccinated females as well as in some males. On the other hand we are confronted with rising incidences e.g. in urethritis with various causative agents and in syphilis cases. Alarmingly during the last 3 years gonococci have become less susceptible to our remaining antibiotics, necessitating strict adherence to updated treatment guidelines. Other trends in STIs and their consequences are discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23446237     DOI: 10.1024/1661-8157/a001200

Source DB:  PubMed          Journal:  Praxis (Bern 1994)        ISSN: 1661-8157


  2 in total

1.  Antibiotic Susceptibility and Sequence Type Distribution of Ureaplasma Species Isolated from Genital Samples in Switzerland.

Authors:  Sarah C Schneider; Regula Tinguely; Sara Droz; Markus Hilty; Valentina Donà; Thomas Bodmer; Andrea Endimiani
Journal:  Antimicrob Agents Chemother       Date:  2015-07-20       Impact factor: 5.191

2.  Importance of extending the use of polymerase chain reaction in the diagnosis of venereal syphilis in a blood transfusion center in Burkina Faso, West Africa.

Authors:  Abibou Simpore; Cyrille Bisseye; Bolni Marius Nagalo; Mahamoudou Sanou; Yacoub Nébié; Laure Stella Ghoma-Linguissi; Honorine Dahourou; Boukary Sawadogo; Florencia Djigma; Siaka Ouattara; Virginio Pietra; Jason Nichol; Jacques Simpore
Journal:  Pan Afr Med J       Date:  2014-05-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.